HOLLY BAUMANN: Open Payments
NPI 1639893159 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 41 payments from 14 companies in 2025. Trend: 2023 $2,745 · 2024 $1,206 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| 180 Medical, Inc. | 9 | $199 |
| Janssen Biotech, Inc. | 5 | $185 |
| Procept Biorobotics Corporation | 1 | $110 |
| UROGEN PHARMA, INC. | 4 | $107 |
| PFIZER INC. | 4 | $76 |
| ABBVIE INC. | 4 | $75 |
| Ferring Pharmaceuticals Inc. | 3 | $67 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Boston Scientific Corporation | 2 | $42 |
| TOLMAR, INC. | 2 | $40 |
Products named: RYBREVANT, AQUABEAM ROBOTIC SYSTEM, XTANDI, JELMYTO, ADSTILADRIN, ERLEADA, KEYTRUDA, LUPRON DEPOT.
Industry payments across IA — which companies pay providers there.
